サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1460197

In vitro転写テンプレート市場：世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年

In-vitro Transcription Templates Market (Disease: Cancer, Infectious Diseases, Lifestyle Diseases, Genetic Diseases, and Others; and Treatment: Vaccine and Therapeutic) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日
ページ情報
英文 233 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
In vitro転写テンプレート市場：世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年
出版日: 2024年02月02日
発行: Transparency Market Research
ページ情報: 英文 233 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In vitro転写テンプレート市場- 調査範囲

TMR社の調査レポート「In vitro転写テンプレートの世界市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界のIn vitro転写テンプレート市場の収益と予測を提供します。また、2023年から2031年までの世界のIn vitro転写テンプレート市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、In vitro転写テンプレート市場を理解しました。

市場スナップショット
2022年の市場価値 2億3,160万米ドル
2031年の市場価値 12億米ドル
CAGR 20%

当レポートでは、世界のIn vitro転写テンプレート市場の競合情勢について調査しています。世界のIn vitro転写テンプレート市場で事業を展開する主要企業が特定され、その各企業がさまざまな属性でプロファイリングされています。企業概要、財務状況、最近の市場開拓、SWOTは、本レポートで紹介されている世界のIn vitro転写テンプレート市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場分析と予測、2017年～2031年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析と予測：疾患別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：疾患別、2017年～2031年
    • がん
      • 固形がん
      • 大腸がん
      • NSCLC
      • 黒色腫
      • 白血病
      • 前立腺がん
      • その他
    • 感染症
      • インフルエンザ
      • COVID-19
      • エイズ
      • その他
    • 生活習慣病
    • 遺伝性疾患
    • その他
  • 市場魅力度：疾患別

第7章 世界市場分析と予測：治療別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：治療別、2017年～2031年
    • ワクチン
    • 治療薬
  • 市場魅力度：治療別

第8章 世界市場分析と予測：研究段階別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：研究段階別、2017年～2031年
    • 探査
    • 臨床
  • 市場魅力度：研究段階別

第9章 世界市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2017年～2031年
    • 製薬企業・バイオテクノロジー企業
    • CRO・CMO
    • 学術・研究機関
    • その他
  • 市場魅力度：エンドユーザー別

第10章 世界市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017-2031年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度：地域別

第11章 北米市場分析と予測

第12章 欧州市場分析と予測

第13章 アジア太平洋市場分析と予測

第14章 ラテンアメリカ市場分析と予測

第15章 中東・アフリカ市場分析と予測

第16章 競合情勢

  • 市場競合マトリックス（ティア別、企業規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs
    • Takara Bio Inc.
    • LGC Limited
    • Enzynomics Co. Ltd.
    • Enzo Life Sciences, Inc.
    • Danaher Corporation
図表

List of Tables

  • Table 01: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 02: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 03: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 05: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 08: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 9: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 10: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 13: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 14: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 15: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 18: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 19: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 20: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 23: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 24: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 25: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 28: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 29: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 30: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global In-vitro Transcription Templates Market Size (US$ Mn), by Region, 2022-2031
  • Figure 02: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Disease, 2022
  • Figure 03: Global In-vitro Transcription Templates Market Value Share, by Disease, 2022
  • Figure 04: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Treatment, 2022
  • Figure 05: Global In-vitro Transcription Templates Market Value Share, by Treatment, 2022
  • Figure 06: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Research Stage, 2022
  • Figure 07: Global In-vitro Transcription Templates Market Value Share, by Research Stage, 2022
  • Figure 08: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by End-user, 2022
  • Figure 09: Global In-vitro Transcription Templates Market Value Share, by End-user, 2022
  • Figure 10: Global In-vitro Transcription Templates Market Value Share, by Region, 2022
  • Figure 11: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 13: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 14: Global In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 15: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 16: Global In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 17: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 18: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global In-vitro Transcription Templates Market Value Share, by End-user, 2022
  • Figure 20: Global In-vitro Transcription Templates Market Value Share Analysis, by Region, 2022-2031
  • Figure 21: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America In-vitro Transcription Templates Market Value Share Analysis, by Country, 2022-2031
  • Figure 25: North America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 26: North America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 27: North America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 28: North America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 29: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 30: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 31: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 32: North America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 33: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Europe In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 37: Europe In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 38: Europe In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 39: Europe In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 40: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 41: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 42: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 43: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 45: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 47: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 48: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 49: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 50: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 52: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 53: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 54: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 55: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 58: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 59: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 60: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 61: Latin America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 62: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 63: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 64: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 65: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 69: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 70: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 71: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 72: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 73: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 74: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 75: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 76: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL43415

In-vitro Transcription Templates Market - Scope of Report

TMR's report on the global in-vitro transcription templates market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global in-vitro transcription templates market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro transcription templates market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in-vitro transcription templates market.

Market Snapshot
Market Value in 2022US$ 231.6 Mn
Market Value in 2031US$ 1.2 Bn
CAGR20%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro transcription templates market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in-vitro transcription templates market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro transcription templates market.

The report delves into the competitive landscape of the global in-vitro transcription templates market. Key players operating in the global in-vitro transcription templates market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in-vitro transcription templates market profiled in this report.

Key Questions Answered in Global in-vitro transcription templates Market Report:

  • What is the sales/revenue generated by in-vitro transcription templates across all regions during the forecast period?
  • What are the opportunities in the global in-vitro transcription templates market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

In-vitro Transcription Templates Market - Research Objectives and Research Approach

The comprehensive report on the global in-vitro transcription templates market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro transcription templates market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in-vitro transcription templates market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In-vitro Transcription Templates Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global In-vitro Transcription Templates Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global In-vitro Transcription Templates Market Analysis and Forecast, by Disease

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disease, 2017-2031
    • 6.3.1. Cancer
      • 6.3.1.1. Solid Tumors
      • 6.3.1.2. Colorectal Cancer
      • 6.3.1.3. NSCLC
      • 6.3.1.4. Melanoma
      • 6.3.1.5. Leukemia
      • 6.3.1.6. Prostate Cancer
      • 6.3.1.7. Others
    • 6.3.2. Infectious Diseases
      • 6.3.2.1. Influenza
      • 6.3.2.2. COVID-19
      • 6.3.2.3. AIDS
      • 6.3.2.4. Others
    • 6.3.3. Lifestyle Diseases
    • 6.3.4. Genetic Diseases
    • 6.3.5. Others
  • 6.4. Market Attractiveness, by Disease

7. Global In-vitro Transcription Templates Market Analysis and Forecast, by Treatment

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Treatment, 2017-2031
    • 7.3.1. Vaccine
    • 7.3.2. Therapeutic
    • 7.3.3. 7.4 Market Attractiveness, by Treatment

8. Global In-vitro Transcription Templates Market Analysis and Forecast, by Research Stage

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Research Stage, 2017-2031
    • 8.3.1. Exploratory
    • 8.3.2. Clinical
  • 8.4. Market Attractiveness, by Research Stage

9. Global In-vitro Transcription Templates Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical & Biotechnology Companies
    • 9.3.2. CROs & CMOs
    • 9.3.3. Academics & Research
    • 9.3.4. Others
  • 9.4. Market Attractiveness, by End-user

10. Global In-vitro Transcription Templates Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America In-vitro Transcription Templates Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disease, 2017-2031
    • 11.2.1. Cancer
      • 11.2.1.1. Solid Tumors
      • 11.2.1.2. Colorectal Cancer
      • 11.2.1.3. NSCLC
      • 11.2.1.4. Melanoma
      • 11.2.1.5. Leukemia
      • 11.2.1.6. Prostate Cancer
      • 11.2.1.7. Others
    • 11.2.2. Infectious Diseases
      • 11.2.2.1. Influenza
      • 11.2.2.2. COVID-19
      • 11.2.2.3. AIDS
      • 11.2.2.4. Others
    • 11.2.3. Lifestyle Diseases
    • 11.2.4. Genetic Diseases
    • 11.2.5. Others
  • 11.3. Market Attractiveness, by Disease
  • 11.4. Market Value Forecast, by Treatment, 2017-2031
    • 11.4.1. Vaccine
    • 11.4.2. Therapeutic
  • 11.5. Market Attractiveness, by Treatment
  • 11.6. Market Value Forecast, by Research Stage, 2017-2031
    • 11.6.1. Exploratory
    • 11.6.2. Clinical
  • 11.7. Market Attractiveness, by Research Stage
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Pharmaceutical & Biotechnology Companies
    • 11.8.2. CROs & CMOs
    • 11.8.3. Academics & Research
    • 11.8.4. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Disease
    • 11.11.2. By Treatment
    • 11.11.3. By Research Stage
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe In-vitro Transcription Templates Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disease, 2017-2031
    • 12.2.1. Cancer
      • 12.2.1.1. Solid Tumors
      • 12.2.1.2. Colorectal Cancer
      • 12.2.1.3. NSCLC
      • 12.2.1.4. Melanoma
      • 12.2.1.5. Leukemia
      • 12.2.1.6. Prostate Cancer
      • 12.2.1.7. Others
    • 12.2.2. Infectious Diseases
      • 12.2.2.1. Influenza
      • 12.2.2.2. COVID-19
      • 12.2.2.3. AIDS
      • 12.2.2.4. Others
    • 12.2.3. Lifestyle Diseases
    • 12.2.4. Genetic Diseases
    • 12.2.5. Others
  • 12.3. Market Attractiveness, by Disease
  • 12.4. Market Value Forecast, by Treatment, 2017-2031
    • 12.4.1. Vaccine
    • 12.4.2. Therapeutic
  • 12.5. Market Attractiveness, by Treatment
  • 12.6. Market Value Forecast, by Research Stage, 2017-2031
    • 12.6.1. Exploratory
    • 12.6.2. Clinical
  • 12.7. Market Attractiveness, by Research Stage
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Pharmaceutical & Biotechnology Companies
    • 12.8.2. CROs & CMOs
    • 12.8.3. Academics & Research
    • 12.8.4. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Disease
    • 12.11.2. By Treatment
    • 12.11.3. By Research Stage
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific In-vitro Transcription Templates Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Disease, 2017-2031
    • 13.2.1. Cancer
      • 13.2.1.1. Solid Tumors
      • 13.2.1.2. Colorectal Cancer
      • 13.2.1.3. NSCLC
      • 13.2.1.4. Melanoma
      • 13.2.1.5. Leukemia
      • 13.2.1.6. Prostate Cancer
      • 13.2.1.7. Others
    • 13.2.2. Infectious Diseases
      • 13.2.2.1. Influenza
      • 13.2.2.2. COVID-19
      • 13.2.2.3. AIDS
      • 13.2.2.4. Others
    • 13.2.3. Lifestyle Diseases
    • 13.2.4. Genetic Diseases
    • 13.2.5. Others
  • 13.3. Market Attractiveness, by Disease
  • 13.4. Market Value Forecast, by Treatment, 2017-2031
    • 13.4.1. Vaccine
    • 13.4.2. Therapeutic
  • 13.5. Market Attractiveness, by Treatment
  • 13.6. Market Value Forecast, by Research Stage, 2017-2031
    • 13.6.1. Exploratory
    • 13.6.2. Clinical
  • 13.7. Market Attractiveness, by Research Stage
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Pharmaceutical & Biotechnology Companies
    • 13.8.2. CROs & CMOs
    • 13.8.3. Academics & Research
    • 13.8.4. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Disease
    • 13.11.2. By Treatment
    • 13.11.3. By Research Stage
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America In-vitro Transcription Templates Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Disease, 2017-2031
    • 14.2.1. Cancer
      • 14.2.1.1. Solid Tumors
      • 14.2.1.2. Colorectal Cancer
      • 14.2.1.3. NSCLC
      • 14.2.1.4. Melanoma
      • 14.2.1.5. Leukemia
      • 14.2.1.6. Prostate Cancer
      • 14.2.1.7. Others
    • 14.2.2. Infectious Diseases
      • 14.2.2.1. Influenza
      • 14.2.2.2. COVID-19
      • 14.2.2.3. AIDS
      • 14.2.2.4. Others
    • 14.2.3. Lifestyle Diseases
    • 14.2.4. Genetic Diseases
    • 14.2.5. Others
  • 14.3. Market Attractiveness, by Disease
  • 14.4. Market Value Forecast, by Treatment, 2017-2031
    • 14.4.1. Vaccine
    • 14.4.2. Therapeutic
  • 14.5. Market Attractiveness, by Treatment
  • 14.6. Market Value Forecast, by Research Stage, 2017-2031
    • 14.6.1. Exploratory
    • 14.6.2. Clinical
  • 14.7. Market Attractiveness, by Research Stage
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Pharmaceutical & Biotechnology Companies
    • 14.8.2. CROs & CMOs
    • 14.8.3. Academics & Research
    • 14.8.4. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Disease
    • 14.11.2. By Treatment
    • 14.11.3. By Research Stage
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa In-vitro Transcription Templates Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Disease, 2017-2031
    • 15.2.1. Cancer
      • 15.2.1.1. Solid Tumors
      • 15.2.1.2. Colorectal Cancer
      • 15.2.1.3. NSCLC
      • 15.2.1.4. Melanoma
      • 15.2.1.5. Leukemia
      • 15.2.1.6. Prostate Cancer
      • 15.2.1.7. Others
    • 15.2.2. Infectious Diseases
      • 15.2.2.1. Influenza
      • 15.2.2.2. COVID-19
      • 15.2.2.3. AIDS
      • 15.2.2.4. Others
    • 15.2.3. Lifestyle Diseases
    • 15.2.4. Genetic Diseases
    • 15.2.5. Others
  • 15.3. Market Attractiveness, by Disease
  • 15.4. Market Value Forecast, by Treatment, 2017-2031
    • 15.4.1. Vaccine
    • 15.4.2. Therapeutic
  • 15.5. Market Attractiveness, by Treatment
  • 15.6. Market Value Forecast, by Research Stage, 2017-2031
    • 15.6.1. Exploratory
    • 15.6.2. Clinical
  • 15.7. Market Attractiveness, by Research Stage
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Pharmaceutical & Biotechnology Companies
    • 15.8.2. CROs & CMOs
    • 15.8.3. Academics & Research
    • 15.8.4. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Disease
    • 15.11.2. By Treatment
    • 15.11.3. By Research Stage
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Thermo Fisher Scientific Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Promega Corporation
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Agilent Technologies, Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. New England Biolabs
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Takara Bio Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. LGC Limited
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Enzynomics Co. Ltd.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Enzo Life Sciences, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Danaher Corporation
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview